Status: Recruiting
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with newly Diagnosed Diffuse Large B-cell Lymphoma
Participants needed: 80
Trial details
Phase: Phase 1, Phase 2Age: 65+Biological sex: AllType: InterventionalSponsor: Mingzhi ZhangUpdated: Nov 12, 2024Locations: 1
Eligibility criteria
Individuals aged 65 years or older who are intolerant to chemotherapy, regardles... [+12]
Clear patients with neurological or psychiatric disorders, including dementia or... [+15]